134 related articles for article (PubMed ID: 36445978)
1. Integrative Oncology in Young Women With Breast Cancer.
Warren Y; Hecksher A; Schepel C; Trufan S; Greiner R; Yaguda S; Bailey-Dorton C; Fisher J; White R; Hadzikadic-Gusic L
Oncology (Williston Park); 2022 Nov; 36(11):658-663. PubMed ID: 36445978
[TBL] [Abstract][Full Text] [Related]
2. Sleep disturbance in cancer patients referred to an ambulatory integrative oncology consultation.
Narayanan S; Reddy A; Lopez G; Liu W; Ali S; Bruera E; Cohen L; Yennurajalingam S
Support Care Cancer; 2022 Mar; 30(3):2417-2425. PubMed ID: 34762218
[TBL] [Abstract][Full Text] [Related]
3. Identifying Factors Associated With Disparities in Access to Integrative Oncology Program.
Ben-Arye E; Lopez AM; Daoud N; Zoller L; Walker E; Davidescu M; Shulman K; Gressel O; Stein N; Brosh S; Schiff E; Samuels N
J Pain Symptom Manage; 2024 Jul; 68(1):10-21. PubMed ID: 38552747
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Integrative Oncology Care and Its Costs.
Standish LJ; Dowd F; Sweet E; Dale L; Weaver M; Osborne B; Andersen MR
Integr Cancer Ther; 2017 Mar; 16(1):85-95. PubMed ID: 27230757
[TBL] [Abstract][Full Text] [Related]
5. Practice Patterns on the Incorporation of Integrative Medicine Into the Oncologic Care of Patients With Cancer.
Narayanan S; Liu W; Lopez G; Fellman B; Reddy A; Subbiah IM; Cohen L; Bruera E
Integr Cancer Ther; 2023; 22():15347354231213045. PubMed ID: 37978821
[TBL] [Abstract][Full Text] [Related]
6. A Quality Brief of an Oncological Multisite Massage and Acupuncture Therapy Program to Improve Cancer-Related Outcomes.
Fink J; Burns J; Perez Moreno AC; Kram JJF; Armstrong M; Chopp S; Maul SJ; Conway N
J Altern Complement Med; 2020 Sep; 26(9):820-824. PubMed ID: 32924553
[No Abstract] [Full Text] [Related]
7. Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer.
Freeman JQ; Sheade J; Zhao F; Olopade OI; Nanda R; Huo D
Integr Cancer Ther; 2023; 22():15347354231185122. PubMed ID: 37462224
[TBL] [Abstract][Full Text] [Related]
8. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.
Segev Y; Lavie O; Stein N; Saliba W; Samuels N; Shalabna E; Raz OG; Schiff E; Ben-Arye E
Support Care Cancer; 2021 Jul; 29(7):4055-4064. PubMed ID: 33404816
[TBL] [Abstract][Full Text] [Related]
9. A Model of an Integrative Approach to Breast Cancer Patients.
Rossi C; Maggiore C; Rossi MM; Filippone A; Guarino D; Di Micco A; Forcina L; Magno S
Integr Cancer Ther; 2021; 20():15347354211040826. PubMed ID: 34670415
[TBL] [Abstract][Full Text] [Related]
10. Integrative Medicine for Ovarian Cancer.
Ben-Arye E; Lavie O; Heyl W; Ramondetta L; Berman T; Samuels N
Curr Oncol Rep; 2023 Jun; 25(6):559-568. PubMed ID: 36939963
[TBL] [Abstract][Full Text] [Related]
11. Implementation of Virtual Integrative Oncology Shared Medical Appointment Series (VIOSMAS) Within Mixed Diagnosis Population.
Loy MH; Prisco L; Parikh C
Integr Cancer Ther; 2024; 23():15347354231223969. PubMed ID: 38243739
[TBL] [Abstract][Full Text] [Related]
12. Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.
Smith CA; Hunter J; Delaney GP; Ussher JM; Templeman K; Grant S; Oyston E
BMC Complement Altern Med; 2018 Oct; 18(1):289. PubMed ID: 30373631
[TBL] [Abstract][Full Text] [Related]
13. Advancing supportive oncology care via collaboration between psycho-oncology and integrative medicine.
Kacel EL; Pereira DB; Estores IM
Support Care Cancer; 2019 Sep; 27(9):3175-3178. PubMed ID: 31062108
[TBL] [Abstract][Full Text] [Related]
14. Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project.
Thompson-Lastad A; Atreya CE; Chao MT; Pollak C; Dhruva A; Santana T; Abrams DI
J Altern Complement Med; 2019 Jul; 25(7):733-739. PubMed ID: 31314561
[No Abstract] [Full Text] [Related]
15. Integrative Oncology Consultations Delivered via Telehealth in 2020 and In-Person in 2019: Paradigm Shift During the COVID-19 World Pandemic.
Narayanan S; Lopez G; Powers-James C; Fellman BM; Chunduru A; Li Y; Bruera E; Cohen L
Integr Cancer Ther; 2021; 20():1534735421999101. PubMed ID: 33655797
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Chemotherapy-Induced Peripheral Neuropathy in Integrative Oncology: A Survey of Acupuncture and Oriental Medicine Practitioners.
Lu Z; Moody J; Marx BL; Hammerstrom T
J Altern Complement Med; 2017 Dec; 23(12):964-970. PubMed ID: 28661695
[TBL] [Abstract][Full Text] [Related]
17. Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study.
Samuels N; Cohen N; Katz D; Ben-Arye E
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10143-10148. PubMed ID: 37264264
[TBL] [Abstract][Full Text] [Related]
18. Adolescent-young adults (AYA) with cancer seeking integrative oncology consultations: demographics, characteristics, and self-reported outcomes.
Lopez G; Liu W; Madden K; Fellman B; Li Y; Bruera E
Support Care Cancer; 2018 Apr; 26(4):1161-1167. PubMed ID: 29082436
[TBL] [Abstract][Full Text] [Related]
19. Advising Women Undergoing Treatment for Breast Cancer: A Narrative Review.
Lemanne D; Maizes V
J Altern Complement Med; 2018; 24(9-10):902-909. PubMed ID: 30247957
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
Krüerke D; Schenker M; Matter-Walstra K
BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
